Search Results - "Dehqanzada, Z A"

Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques by Van Rompay, K K, Marthas, M L, Lifson, J D, Berardi, C J, Vasquez, G M, Agatep, E, Dehqanzada, Z A, Cundy, K C, Bischofberger, N, Pedersen, N C

“…Simian immunodeficiency virus (SIV) infection of newborn macaques is a useful animal model to explore novel strategies to reduce perinatal human…”
Get more information

Developing a predictive model for disease status in breast cancer patients using Th1 and Th2 serum cytokine profiles by Khoo, S., Kao, T., Dehqanzada, Z. A., Storrer, C. E., Harris, K. A., Jama, Y. H., Shriver, C. D., Ponniah, S., Peoples, G. E.

“…Abstract only 10078 Background: Using the Luminex multiplex assay, we have reported significant correlations between serum levels of MCP-1, eotaxin, and IL-6…”
Get full text

Early results of a phase I clinical trial of an Ii-Key/Her2/ neu MHC class II peptide-based vaccine in breast cancer patients by Mittendorf, E. A., Khoo, S., Storrer, C. E., Harris, K. A., Jama, Y. H., Dehqanzada, Z. A., Murray, J. L., Shriver, C. D., Von Hofe, E., Ponniah, S., Peoples, G. E.

“…Abstract only 2532 Background: HER2/neu is over-expressed in breast cancer (BCa) and is the source of immunogenic peptides currently being evaluated in…”
Get full text

Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex registered technology by Dehqanzada, Z A, Storrer, CE, Hueman, M T, Foley, R J, Harris, KA, Jama, Y H, Shriver, C D, Ponniah, S, Peoples, GE

“…We used the Luminex assay to compare serum cytokine profiles of breast cancer patients (BCa) to healthy controls, node-positive (NP) patients to node-negative…”
Get full text

Phase I Clinical Trial of a HER-2/neu Peptide (E75) Vaccine for the Prevention of Prostate-Specific Antigen Recurrence in High-Risk Prostate Cancer Patients by HUEMAN, Matthew T, DEHQANZADA, Zia A, PONNIAH, Sathibalan, PEOPLES, George E, NOVAK, Thomas E, GURNEY, Jennifer M, WOLL, Michael M, RYAN, Gayle B, STORRER, Catherine E, FISHER, Christine, MCLEOD, David G, IOANNIDES, Constantine G

“…Purpose: The E75 peptide is an immunogenic peptide from the HER-2/ neu protein that is substantially expressed in prostate cancer. We are conducting a clinical…”
Get full text

Correlations between Serum Monocyte Chemotactic Protein-1 Levels, Clinical Prognostic Factors, and HER-2/neu Vaccine-Related Immunity in Breast Cancer Patients by DEHQANZADA, Zia A, STORRER, Catherine E, HUEMAN, Matthew T, FOLEY, Rebecca J, HARRIS, Katie A, JAMA, Yusuf H, KAO, Tzu-Cheg, SHRIVER, Craig D, PONNIAH, Sathibalan, PEOPLES, George E

“…Purpose: We studied serum monocyte chemotactic protein-1 (MCP-1) levels in breast cancer patients in relationship to their clinicopathologic variables and…”
Get full text